Prospective trials on anemia of chronic disease:: The Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT)

被引：16

作者：

Rao, M ^{[1
]}

Pereira, BJG ^{[1
]}

机构：

[1] Tufts Univ New England Med Ctr, Boston, MA 02111 USA

来源：

KIDNEY INTERNATIONAL | 2003年 / 64卷

关键词：

kidney disease; Aranesp (R); renal replacement therapy; rHuEPO;

D O I：

10.1046/j.1523-1755.64.s87.21.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S12 / S19

页数：8

共 77 条

[1] Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction [J].

Al-Ahmad, A ;

Rand, WM ;

Manjunath, G ;

Konstam, MA ;

Salem, DN ;

Levey, AS ;

Sarnak, MJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :955-962

[2]

[Anonymous], 1997, Am J Kidney Dis, V30, pS192

[3] Association of kidney function with anemia - The Third National Health and Nutrition Examination Survey (1988-1994) [J].

Astor, BC ;

Muntner, P ;

Levin, A ;

Eustace, JA ;

Coresh, J .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (12) :1401-1408

[4] Defining a renal anemia management period [J].

Besarab, A ;

Levin, A .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (06) :S13-S23

[5]

Besarab A, 1995, Curr Opin Nephrol Hypertens, V4, P155, DOI 10.1097/00041552-199503000-00008

[6] European best practice guidelines for the management of anaemia in patients with chronic renal failure [J].

Cameron, JS .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 :61-65

[7]

*CAN SOC NEPHR TRE, 1999, J AM SOC NEPHROL, V10, pS292

[8] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].

Chobanian, AV ;

Bakris, GL ;

Black, HR ;

Cushman, WC ;

Green, LA ;

Izzo, JL ;

Jones, DW ;

Materson, BJ ;

Oparil, S ;

Wright, JT ;

Roccella, EJ .

HYPERTENSION, 2003, 42 (06) :1206-1252

[9] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[10] United states renal data system assessment of the impact of the national kidney foundation-dialysis outcomes quality initiative guidelines [J].

Collins, AJ ;

Roberts, TL ;

Peter, WLS ;

Chen, SC ;

Ebben, J ;

Constantini, E .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (04) :784-795

← 1 2 3 4 5 6 7 8 →